# Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)

> **NCT00909168** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Udine, Italy** · enrollment: 130 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** FLAIMy - Fluda, Ida, Ara-C, Mylotarg

## Key facts

- **NCT ID:** NCT00909168
- **Lead sponsor:** University Hospital, Udine, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-05
- **Final completion:** 2013-03
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909168, "Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00909168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*